LifeStance Health Q1 2026: Revenue at $343.9 Million, Net Loss of $45.2 Million

LifeStance Health released its financial results for the first quarter of 2026, revealing key figures regarding revenue, losses, and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA). The company also provided its financial outlook for the second quarter and full year of 2026.

Specifically, LifeStance reported a net revenue of $343.9 million for the first quarter. However, the company experienced a net loss of $45.2 million, which translates to a loss of $0.14 per share. On a more positive note, LifeStance reported an adjusted EBITDA of $44.8 million for the same period. Looking ahead, the company anticipates net revenue between $360 million and $370 million for the second quarter of 2026. Furthermore, LifeStance projects a full-year 2026 net revenue in the range of $1.48 billion to $1.52 billion.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: May 7, 2026

Author

GOAI